NanoVibronix Responds To CMS' Determination For PainShield Not Reimbursable Under Medicare And Medicaid
Portfolio Pulse from Happy Mohamed
NanoVibronix, Inc. (NASDAQ:NAOV) has responded to the Centers for Medicare & Medicaid Services' (CMS) determination that its PainShield device is not reimbursable under Medicare and Medicaid. The company is working to understand the implications and plans to address CMS' concerns and resubmit an application for additional review. Despite the setback, NanoVibronix continues to grow the distribution of PainShield in other sectors.
August 29, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NanoVibronix's PainShield device is not reimbursable under Medicare and Medicaid, potentially impacting the company's revenue. However, the company is planning to address the issue and resubmit an application for review.
The CMS decision directly affects NanoVibronix's PainShield device, potentially limiting its market reach and impacting the company's revenue. However, the company's proactive approach to address the issue and resubmit an application for review could mitigate the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100